Skip to main content
MET logo

MET · Metlife Inc · Financials

Track MET — free
$102.89 +2.22 (+2.21%) At close · Nov 4 Earnings today Play latest call Q2 2026 earnings call transcript
Market Cap
$63.97B
Shares
635.48M
Volume · Nov 4 5.41M Avg daily vol (3M) 3.12M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$77.08B +8.6%
FY2025 Revenue FY2007–FY2025
Net Income
$3.38B -23.7%
FY2025 Net Income FY2007–FY2025
Operating Margin
7.96% -0.5pp
FY2025 Operating Margin FY2022–FY2025
Diluted EPS
$4.71 -20.7%
FY2025 Diluted EPS FY2007–FY2025
Operating Cash Flow
$17.09B +17.1%
FY2025 Operating Cash Flow FY2007–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008 FY2007
$79.4B $77.08B $70.99B $66.91B $68.77B $68.7B $67.84B $69.62B $67.94B $62.31B $60.79B $61.34B $73.32B $68.2B $68.15B $70.24B $52.25B $40.66B $50.98B $47.15B
$50.8B $49.78B $44.95B $44.28B $48.51B $41.15B $42.03B $42.24B $43.84B $38.99B $37.2B $36.4B $39.07B $37.67B $37.98B $36.36B $27.07B $26.16B $25.91B $22.97B
— $358M $341M $366M $392M — — — — — — — — — — — — — — —
$7.7B $6.79B $6.02B $5.82B $5.27B $5.46B $5.6B $6B $5.71B $5.39B $5.74B $6.11B — — — — — — — —
$590M $560M $481M $828M $669M $670M $761M $901M $910M $1.13B $1.01B $1.42B — — — — — — — —
— $83M $85M $88M $92M $100M $41M $42M $47M $51M $57M $56M $82M $84M $150M $60M $42M — — —
— — — — — — — — — — — — — — $159M — — — — —
— — — — — — — — — — — — — — — $0 $48M $160M $0 —
$14.83B $13.86B $13.02B $12.71B $11.86B $12.02B $13.15B $13.69B $13.71B $13.62B $13.75B $14.78B $17.09B $16.6B $17.76B $18.54B $12.93B $10.52B $11.95B $10.41B
$6.56B $6.14B $6B $5.72B $5.98B — — — — — — — — — — — — — — —
— 7.96% 8.45% 8.55% 8.69% — — — — — — — — — — — — — — —
— — — — — — — — — — — — — — — — $1.55B $1.04B $1.05B —
$1.86B $1.55B $988M $151M $1.31B $5.14B $829M $795M $592M — — — — — — — $430M -$1.12B -$679M -$606M
-$1.58B -$1.15B -$1.18B -$2.82B -$1.26B $1.54B -$110M $444M -$298M -$308M $317M $609M -$197M $161M -$352M -$867M -$408M -$2.9B -$2.1B -$578M
$4.87B $4.66B $5.62B $2.16B $6.36B $8.52B $6.93B $6.8B $6.31B $3.54B $4.28B $5.65B $8.8B $4.05B $1.44B $9.18B $3.73B -$4.36B — —
$1.21B $1.26B $1.18B $560M $1.06B $1.64B $1.51B $886M $1.18B -$1.47B $693M $1.59B $2.47B $661M $128M $2.79B $1.11B -$2.03B $1.58B $1.68B
$3.63B $3.38B $4.43B $1.58B $5.28B $6.86B $5.41B $5.9B $5.12B $4.01B $850M $5.37B $6.31B $3.37B $1.32B $6.42B $2.67B -$2.25B $3.21B $4.32B
— 4.38% 6.24% 2.36% 7.68% 9.98% 7.97% 8.47% 7.54% 6.44% 1.4% 8.76% 8.61% 4.94% 1.94% 9.14% 5.1% -5.52% 6.29% 9.16%
$33M $24M $18M $24M $18M $21M $11M $10M $5M $10M $4M $12M $27M $25M $38M -$8M $4M $32M $69M $148M
$3.44B $3.17B $4.23B $1.38B $5.1B $6.65B $5.19B $5.72B $4.98B $3.91B $747M $5.22B $6.19B $3.25B $1.2B $6.16B $2.55B -$2.37B $3.08B $4.18B
$4.74B $7.56B $2.48B $4.96B -$14.89B $4.09B $10.43B $17.21B -$1.49B $7.39B $1.45B -$574M $11.85B -$2.93B $6.64B $11.36B $6.86B $8.98B -$12.29B $4.47B
USD/shares $5.26 $4.74 $5.98 $1.82 $6.35 $7.71 $5.72 $6.10 $4.95 $3.65 $0.68 $4.67 $5.48 $2.94 $1.12 $5.81 $2.88 -$2.89 $4.19 $5.62
USD/shares $5.23 $4.71 $5.94 $1.81 $6.30 $7.65 $5.68 $6.06 $4.91 $3.62 $0.67 $4.62 $5.42 $2.91 $1.12 $5.76 $2.86 -$2.89 $4.14 $5.48
shares — 668.9M 706.4M 757.7M 803.2M 862.7M 907.8M 937.6M 1.01B 1.07B 1.1B 1.12B 1.13B 1.11B 1.07B 1.06B 882.44M 818.46M 735.18M —
shares — 673.3M 711.1M 762.3M 808.9M 869.4M 913.2M 944.4M 1.01B 1.08B 1.11B 1.13B 1.14B 1.12B 1.08B 1.07B 889.57M 818.46M 744.79M —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $33.43B in buybacks, $24.67B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt and lease obligations, including current maturities 2026-06-30 USD 14,244,000,000 10-Q filed 2026-08-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Secured debt, including current maturities
USD 286,000,000
Short-term borrowings 2026-06-30 USD 460,000,000 10-Q filed 2026-08-06
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056

Note · MetLife, Inc.

Reference: 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056

Active
Original principal
USD 1,000,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—

Last reported interest terms: 5.85% Reported 2026-02-26 Later filings may not restate these terms; this does not confirm they still apply.

Covenant terms for this agreement are not yet verified.

Documents and filing history
  1. Issuance · 2026-02-26 Original principal USD 1,000,000,000 Exact source document Parent 8-K filing · 2026-02-26
    On February 26, 2026, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056 (the “Debentures”). The Debentures were issued pursuant to the Indenture, dated as of June 21, 2005 (incorporated by reference to Exhibit 4.41(a) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010), between the Company and The Bank of New York Mellon Trust Company, N.A., (as successor in interest to J.P. Morgan Trust Company, National Association), as trustee (the “Trustee”), as supplemented by the Fourteenth Supplemental Indenture, dated as of February 26, 2026, with respect to the Debentures (attached hereto as Exhibit 4.2 and incorporated herein by reference).
    Issuer evidence: On February 26, 2026, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056 (the “Debentures”). The Debentures were issued pursuant to the Indenture, dated as of June 21, 2005 (incorporated by reference to Exhibit 4.41(a) to the Company’s Annual Report on Form 10-K for the year ended December 31, 2010), between the Company and The Bank of New York Mellon Trust Company, N.A., (as successor in interest to J.P. Morgan Trust Company, National Association), as trustee (the “Trustee”), as supplemented by the Fourteenth Supplemental Indenture, dated as of February 26, 2026, with respect to the Debentures (attached hereto as Exhibit 4.2 and incorporated herein by reference).
    Supporting evidence: On February 26, 2026, MetLife, Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of its 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2056 (the “Debentures”).

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.67×
Peer median 1.24×
EV/EBIT
8.10×
P/E (TTM)
19.25×
Peer median 11.32×
Price/Sales (TTM)
0.81×
Peer median 1.44×
Price/Book
2.33×
Peer median 1.36×

Peer medians compare against the 8 similar-size Insurance - Life companies (of 19 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Group Benefits Segment $26,881,000,000 $26,122,000,000 $25,230,000,000 $24,402,000,000 $23,703,000,000 — — —
Retirement and Income Solutions Segment $21,036,000,000 $17,076,000,000 $16,635,000,000 $20,518,000,000 $12,521,000,000 — — —
Asia Segment $11,955,000,000 $11,415,000,000 $10,926,000,000 $11,255,000,000 $13,172,000,000 $12,462,000,000 $12,053,000,000 $11,764,000,000
Latin America Segment $8,304,000,000 $7,586,000,000 $7,371,000,000 $6,031,000,000 $5,061,000,000 $4,289,000,000 $5,132,000,000 $5,084,000,000
EMEA Segment $3,154,000,000 $2,770,000,000 $2,543,000,000 $2,441,000,000 $2,923,000,000 $3,013,000,000 $2,945,000,000 $2,921,000,000
MetLife Investment Management Segment $938,000,000 $725,000,000 $722,000,000 — — — — —
MetLife Holdings Segment — $7,257,000,000 $8,202,000,000 $9,037,000,000 $10,898,000,000 $10,095,000,000 $10,406,000,000 $10,726,000,000
United States Segment — — — $45,802,000,000 $37,084,000,000 $36,195,000,000 $35,787,000,000 $37,037,000,000
Corporate And Other — — $808,000,000 $655,000,000 $766,000,000 $411,000,000 $651,000,000 $629,000,000

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Prepaidlegalplansandadministrativeonlycontracts $637,000,000 $572,000,000 $516,000,000 $471,000,000 $432,000,000 $395,000,000 $347,000,000 $296,000,000
Vision Fee For Service Arrangements $561,000,000 $536,000,000 $598,000,000 $566,000,000 $546,000,000 $0 $0 —
Otherrevenuefromservicecontractsfromcustomers $432,000,000 $412,000,000 $390,000,000 $271,000,000 $289,000,000 $227,000,000 $240,000,000 $241,000,000
Feebasedinvestmentmanagementservices $369,000,000 $301,000,000 $316,000,000 $396,000,000 $363,000,000 $318,000,000 $286,000,000 $293,000,000
Administrative Service $295,000,000 $273,000,000 $259,000,000 $238,000,000 $231,000,000 $218,000,000 $210,000,000 $205,000,000
Distribution Service $142,000,000 $151,000,000 $150,000,000 $168,000,000 $213,000,000 $196,000,000 $206,000,000 $221,000,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Asia Segment $1,702,000,000 $1,621,000,000 $1,282,000,000 $1,617,000,000 $2,517,000,000 $1,565,000,000 $1,405,000,000 $1,237,000,000
Group Benefits Segment $1,692,000,000 $1,606,000,000 $1,655,000,000 $1,332,000,000 $463,000,000 — — —
Retirement and Income Solutions Segment $1,671,000,000 $1,667,000,000 $1,708,000,000 $1,635,000,000 $2,591,000,000 — — —
Latin America Segment $798,000,000 $881,000,000 $840,000,000 $729,000,000 $274,000,000 $280,000,000 $609,000,000 $592,000,000
EMEA Segment $367,000,000 $283,000,000 $265,000,000 $249,000,000 $306,000,000 $327,000,000 $282,000,000 $277,000,000
MetLife Investment Management Segment $200,000,000 $55,000,000 $70,000,000 — — — — —
MetLife Holdings Segment — $647,000,000 $733,000,000 $1,031,000,000 $2,103,000,000 $976,000,000 $1,034,000,000 $1,255,000,000
United States Segment — — — $2,996,000,000 $3,221,000,000 $3,224,000,000 $2,838,000,000 $2,804,000,000
Corporate And Other — — -$760,000,000 -$615,000,000 -$156,000,000 -$547,000,000 -$223,000,000 -$563,000,000

Operating Margin by Segment (%)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Group Benefits Segment 6.3% 6.1% 6.6% 5.5% 2% — — —
Retirement and Income Solutions Segment 7.9% 9.8% 10.3% 8% 20.7% — — —
Asia Segment 14.2% 14.2% 11.7% 14.4% 19.1% 12.6% 11.7% 10.5%
Latin America Segment 9.6% 11.6% 11.4% 12.1% 5.4% 6.5% 11.9% 11.6%
EMEA Segment 11.6% 10.2% 10.4% 10.2% 10.5% 10.9% 9.6% 9.5%
MetLife Investment Management Segment 21.3% 7.6% 9.7% — — — — —
MetLife Holdings Segment — 8.9% 8.9% 11.4% 19.3% 9.7% 9.9% 11.7%
United States Segment — — — 6.5% 8.7% 8.9% 7.9% 7.6%
Corporate And Other — — -94.1% -93.9% -20.4% -133.1% -34.3% -89.5%
Key facts CIK 1099219 CUSIP 59156R108 13F (30d) 759 filings 717 filers Visit website Investor relations